Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chunxiao Cheng
Observed name:
Cheng, Chunxiao
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital
Observed institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0002-4696-0520
Observed ORCID:
0000-0002-4696-0520
OpenAlex ID:
A5061746603
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma
2023
·
Binghua Li
, Yunzheng Li
, et al.
·
Hepatology
·
119
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
2022
·
Yunzheng Li
, Binghua Li
, et al.
·
Cancer Research
·
99
β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma
2024
·
Ye Wang
, Chunxiao Cheng
, et al.
·
Cancer Research
·
33
Letter to the editor: the inflamed subclass predicts immunotherapy response – external validations
2022
·
Binghua Li
, Yajuan Cao
, et al.
·
Gut
·
18
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
2023
·
Laizhu Zhang
, Ke Su
, et al.
·
BMC Cancer
·
8
PDF
Integrating population-level and cell-based signatures for drug repositioning
2025
·
Chunfeng He
, Yue Xu
, et al.
·
Bioinformatics
·
4
PDF
Combined clinical features and MRI parameters for the prediction of VEGFR2 in hepatocellular carcinoma patients
2022
·
Laizhu Zhang
, Chunxiao Cheng
, et al.
·
Frontiers in Oncology
·
4
GOT1 inhibits hepatocellular carcinoma progression by regulating SLC25A5-dependent mitochondrial apoptosis
2026
·
Weiwei Zong
, Chunxiao Cheng
, et al.
·
Oncogene
·
3
PDF
A multi-modal framework improves prediction of tissue-specific gene expression from a surrogate tissue
2024
·
Yue Xu
, Chunfeng He
, et al.
·
EBioMedicine
·
2
Donafenib combined with camrelizumab and transarterial chemoembolization (TACE) as conversion therapy for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm, phase II study.
2023
·
Yajuan Cao
, Xuebin Zhang
, et al.
·
Journal of Clinical Oncology
·
2
Supplementary Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma
2024
·
Ye Wang
, Chunxiao Cheng
, et al.
Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma
2024
·
Ye Wang
, Chunxiao Cheng
, et al.
Supplementary Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma
2024
·
Ye Wang
, Chunxiao Cheng
, et al.
Data from β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma
2024
·
Ye Wang
, Chunxiao Cheng
, et al.
Show more works
View as search
Works count:
16
Citation count:
292
H-index:
5
I10-index:
4
Year
Topic
Type